-
1.One-stage repair of perineal hypospadias and scrotal transposition. Eur. Urol., 10: 364-367
Koyanagi T., Nonomura K., Gotoh T., Nakanishi S. and Kakizaki H. (1984)
-
2.Sympathetic innervation of the male feline urethral rhabdosphincter. Neuroscience Letters, 129: 165-167.
Kakizaki H., Koyanagi T. and Kato M. (1991)
-
3.Relevance of detrusor hyperreflexia, vesical compliance and urethral pressure to occurrence of vesicoureteral reflux in myelodysplastic patients. J. Urol., 147(2):413-415.
Kobayashi S., Shinno Y., Kakizaki H. and Koyanagi T. (1992)
-
4.Experience with one-stage repair of severe proximal hypospadias: Operative technique and results. Eur. Urol., 24:106-110.
Koyanagi T., Nonomura K., Kakizaki H., Takeuchi I. and Yamashita T. (1993)
-
5.An electromyographic study on the urethral rhabdosphincter in normal and chronically rhizotomized cats: analysis of electrical potentials evoked by sympathetic nerve stimulation. J. Urol., 151: 238-243.
Kakizaki H., Koyanagi T., Shinno Y., Kobayashi S., Matsumura K. and Kato M. (1994)
-
6.Preexisting neurogenic voiding dysfunction in children with imperforate anus: problems in management. J. Urol., 151: 1041-1044.
Kakizaki H., Nonomura K., Asano Y., Shinno Y., Ameda K. and Koyanagi T. (1994)
-
7.One-stage repair of hypospadias: is there no simple method universally applicable to all types of hypospadias? J. Urol., 152: 1232-1237.
Koyanagi T., Nonomura K., Yamashita T., Kanagawa K. and Kakizaki H. (1994)
-
8.Fascial sling for the management of urinary incontinence due to sphincter incompetence. J. Urol., 153: 644-647.
Kakizaki H., Shibata T., Shinno Y., Kobayashi S., Matsumura K. and Koyanagi T. (1995)
-
9.Continence mechanism of the orthotopic neobladder: Urodynamic analysis of ileocolic neobladder and external urethral sphincter function. Int. J. Urol., 2: 267-272.
Kakizaki H., Shibata K., Ameda K., Shinno Y., Nonomura K. and Koyanagi T. (1995)
-
10.Role of spinal nitric oxide in the facilitation of the micturition reflex by bladder irritation. J. Urol., 155: 355-360.
Kakizaki H. and de Groat W.C. (1996)
-
11.Role of NMDA and AMPA glutamatergic transmission in spinal c-fos expression after urinary tract irritation. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R990-996.
Kakizaki H., Yoshiyama M. and de Groat W.C. (1996)
-
12.Reflex pathways controlling urethral striated and smooth muscle function in the male rat. Am. J. Physiol.272 (Regulatory Integrative Com. Physiol. 41) : R1647-1656.
Kakizaki H., Fraser M.O. and de Groat W.C. (1997)
-
13.Reorganization of somato-urethral reflexes following spinal cord injury in the rat. J. Urol., 158:1562-1567.
Kakizaki H. and de Groat, W.C. (1997)
-
14.Role of glutamatergic transmission in the ascending limb of the micturition reflex pathway in the rat. J. Pharmacol. Exp. Ther. 285: 22-27
Kakizaki H., Yoshiyama M., Roppolo J.R., Booth A.M. and de Groat W.C. (1998)
-
15.Clinical features of vesicoureteral reflux in infants and outcome of conservative therapeutic approach. Eur. Urol., 34: 221-225
Kakizaki H., Nonomura K., Yamashita T., Shibata T., Koyama T. and Koyanagi T. (1998)
-
16.Current view and status of the treatment of lower urinary tract symptoms and neurogenic lower urinary tract dysfunction. Brit. J. Urol., 85 (Suppl. 2): 25-30
Kakizaki H. and Koyanagi T. (2000)
-
17.Effects of WAY100635, a selective 5-HT1A-receptor antagonist on the micturition-reflex pathway in the rat. Am. J. Physiol., Regulatory Integrative Comp. Physiol., 280: R1407-R1413
Kakizaki H., Yoshiyama M., Koyanagi T., de Groat W.C. (2001)
-
18.Clinical experience in lower urinary tract symptoms. Brit. J. Urol., 88 (Suppl. 2): 23-26
Kakizaki H. Machino R. and Koyanagi T. (2001)
-
19.Questionnaire analysis on sex difference in lower urinary tract symptoms. Urology, 59: 58-62
Kakizaki H., Matsuura S., Mitsui T., Ameda K., Tanaka H. and Koyanagi T. (2002)
-
20.Human brain region response to distension or cold stimulation of the bladder: A positron emission tomography study. J. Urol., 168: 2035-2039
Matsuura S., Kakizaki H., Mitsui T., Shiga T., Tamaki N. and Koyanagi T. (2002)
-
21.NK1 receptor and its interaction with NMDA receptor in spinal c-fos expression after lower urinary tract irritation. Am. J. Physiol., Regul. Integr. Comp. Physiol., 283: R576-R582
Mitsui T., Kakizaki H., Matsuura S., Tanaka H., Ameda K., Yoshioka M. and Koyanagi T. (2002)
-
22.Urodynamic effects of α1-blocker tamsulosin on voiding dysfunction in patients with neurogenic bladder. Int. J. Urol., 10: 576-581.
Kakizaki H., Ameda K., Kobayashi S., Tanaka H., Shibata T. and Koyanagi T. (2003)
-
23.Brain activation during detrusor overactivity in patients with Parkinson’s disease: A positron emission tomography study. J. Urol., 175: 994-998.
Kitta T, Kakizaki H, Furuno T, Moriya K, Tanaka H, Shiga T, Tamaki N, Yabe I, Sasaki H, Nonomura K. (2006)
-
24.Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms －ASSIST, randomized controlled study. Urology, 78: 126-133.
Yamaguchi O, Kakizaki H, Homma Y, Takeda M, Nishizawa O, Gotoh M, Yokoyama O, Seki N, Yoshida M, on behalf of the ASSIST Study group. (2011)
-
25.Models for sensory neurons of dorsal root ganglia and stress urinary incontinence. Neurourol. Urodyn., 30: 653-657.
Kakizaki H, Kita M, Wada N. (2011)
-
26.A phase III, randomized, double-blind, placebo-controlled study of the β3-adrenoceptor agonist, mirabegron 50 mg once-daily, in Japanese patients with overactive bladder. BJU Int, 113: 951-960.
Yamaguchi O, Marui E, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Ikeda Y, Ohkawa S. (2014)
-
27.Safety and efficacy of mirabegron as add-on therapy in patients with overactive bladder treated with solifenacin: a postmarketing, open-label study in Japan (MILAI study). BJU Int., 116: 612-622.
Yamaguchi O, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Okitsu A, Hamada T, Kobayashi A, Kuroishi K.. (2015)
-
28.Pathophysiological and therapeutic considerations for non-neurogenic lower urinary tract dysfunction in children. LUTS, 8: 75-85.
Kakizaki H, Kita M, Watanabe M, Wada N. (2016)
-
29.Mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A randomized, placebo-controlled study (MATCH). European Urology Focus, doi.org/10.1016/ j.euf.2019.10.019
Kakizaki H, Lee K-S, Yamamoto O, Jong JJ, Katou D, Sumarsono B, Uno S, Yamaguchi O. (2019)
-
30.Managing sphincter deficiency stress urinary incontinence in the neurogenic patients: Diagnosis and management strategies. Curr Bladder Dusfunct Rep, 24, October,1-6, 2020. DOI: 10.1007/s11884-020-00604-1
Kakizaki H, Wada N, Watanabe M, Kita M, Hori J, Tamaki G.（2020）
